Commercial

In complex environments, opportunity is rarely obvious. It sits across patient segments, physician behaviours, unmet needs, and evolving market dynamics.

We bring these elements together into a coherent market view, identifying where meaningful opportunity exists and what is driving it.

Key areas of focus:

• Market mapping across patient and physician segments
• Identification of unmet needs, barriers, and drivers
• Customer beliefs, behaviours, and decision dynamics
• Competitive positioning and whitespace identification
• Market trends and evolution of need over time
• Opportunity-led SWOT and strategic intervention points

Giving you clarity on where the best opportunities sit, what is driving them, and where to focus.

In pharma, critical decisions are made ahead of clinical readouts, competitor moves, and market shifts that are inherently uncertain.

We structure this uncertainty into clear scenarios, allowing you to stress-test strategy and move forward with confidence.

Key areas of focus:

• Identification of high-impact, high-uncertainty variables
• Futures based on clinical, competitive and market events
• Scenario stress-testing strategy and positioning
• Future proofed moves with trigger-based inflections
• Strategic flexibility and contingency planning
• Alignment around robust, future-ready direction

Helping you move forward with confidence in the face of uncertainty.

Combining consulting expertise with a proprietary base of competitor profiles and strategy archetypes, we construct credible forward-looking competitor strategies.

We translate these into portfolio- and market-level themes that shape future HCP behaviour and enable confident, proactive decision-making.

Key areas of focus:

• Strategies from clinical, commercial, and portfolio signals
• Competitor archetypes to anticipate future positioning
• Market-level themes shaping HCP behaviour
• Competitive war-gaming and scenario development
• Response strategy across clinical and commercial levers
• Integration into brand and portfolio strategy

Designed to give you clarity on how competitors will act and how to stay ahead.

Portfolio strategy is shaped by trade-offs across assets, indications, and time, not by individual brands in isolation.

We bring clarity to these dynamics, aligning teams around a coherent and differentiated portfolio direction.

Key areas of focus:

• Portfolio role definition and asset positioning
• Indication and sequencing strategy across lines of therapy
• Internal competition and cannibalisation management
• Alignment of clinical, commercial, and lifecycle strategy
• Long-term portfolio evolution and roadmap development

Giving you clarity on the role of each asset, the trade-offs that matter, and how to maximise portfolio value over time.

Launch success is driven by a small number of critical choices made early, not broad or unfocused ambition.

We work to your brand planning cycle to create clear, differentiated strategies that connect clinical value to commercial impact and guide execution.

Key areas of focus:

• Brand positioning and differentiation strategy
• Strategic imperatives and critical success factors
• Pre-launch and early launch planning
• Evidence and narrative alignment
• Roadmapping and evolution of strategy over time

Providing a clear, differentiated strategy that guides early decisions and strengthens launch performance over time.

Translate strategy into clear, actionable plans that drive impact.

We design practical plans that connect strategic priorities to real-world activity, ensuring teams are clear on what to do, when, and why.

Key areas of focus:

• Translation of strategy into actionable tactical plans
• Stakeholder mapping, prioritisation, and engagement
• Key moments, channels, and intervention points
• Cross-functional and cross-market alignment planning
• Integration with brand, evidence, and launch strategy

Focusing effort where it will have the greatest impact, align stakeholders, and move the strategy forward.